The Effect of Including Bone in Dixon-Based Attenuation Correction for 18F-Fluciclovine PET/MRI of Prostate Cancer

Conclusion: The investigated method for atlas-based inclusion of bone in 18F-fluciclovine PET/MRI attenuation correction has only a small effect on the SUVs of soft-tissue prostate cancer lesions, and no effect on their lesion–to–bone marrow SUVRs when using signal from L3 as a reference. The attenuation maps should always be checked for registration artifacts for lesions in or close to the bones.

http://jnm.snmjournals.org/cgi/content/short/59/12/1913?rss=1

Source: Journal of Nuclear Medicine - December 3, 2018 Category: Nuclear Medicine Authors: Elschot, M., Selnaes, K. M., Johansen, H., Kruger-Stokke, B., Bertilsson, H., Bathen, T. F. Tags: Physics and Instrumentation Source Type: research